Garg Vipin K 4

What Happened

• Vipin Garg, a director of Altimmune, had 41,200 restricted stock units (RSUs) convert into common shares on January 27, 2026. The conversion price was $0.00 per share (RSUs → shares).
• To satisfy tax withholding, 17,898 of those shares were surrendered to the company at a reported value of $6.18 per share, totaling $110,610. Net shares retained by Garg from this vesting event were approximately 23,302.

Key Details

• Transaction date: 2026-01-27 (reported on Form 4 filed 2026-01-29).
• Actions reported: M = exercise/conversion of RSUs (41,200 shares); F = shares surrendered for tax withholding (17,898 shares at $6.18 each, $110,610).
• Net new shares retained after withholding: ~23,302 (41,200 acquired − 17,898 withheld).
• Shares owned after the transaction: not specified in the filing.
• Footnotes: F1–F3 state each RSU converts to one share at vesting, withheld shares were solely to cover taxes, RSUs vest in equal annual installments over 4 years from Jan 27, 2025, and have no expiration date.
• Filing timeliness: Filing appears timely (transaction 1/27/2026, Form 4 filed 1/29/2026).

Context

• This was a vesting/conversion of RSUs, not an open-market purchase or a discretionary sale; surrendering shares to cover taxes is a routine withholding action and does not necessarily indicate a trading decision.
• For retail investors, purchases or outright open-market sales by insiders generally carry more interpretive weight; vesting-related withholding is common compensation processing.